This rat-derived IgG1kappa monoclonal antibody (MJ18) specifically inhibits mouse CD276/B7-H3. It is a valuable tool for investigating the immunomodulatory role of this checkpoint molecule in both in vitro assays and in vivo tumor immunology models.
Target:
B7
* VAT and and shipping costs not included. Errors and price changes excepted